Sign In
26 Nov 2020 07:00
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
26 November 2020
Remote Monitored Systems plc ("RMS" or the "Company")
Update on P2F
The Company is providing the following update on its wholly owned subsidiary Pharm 2 Farm Limited ("P2F").
As noted in the Company's announcement of 11 November 2020, the Directors have been expecting the delivery and installation of its new anti-viral mask production line at or around the end of November. Yesterday, 25 November 2020, the Company received an update from P2F and the manufacturer of the production line noting that the production machinery is now expected to undergo final acceptance testing in mid-December at the manufacturer's premises in Spain. It will then be shipped, installed and commissioned at P2F's Biocity premises in Nottingham. Commercial production and shipment of product is now expected to begin in January 2021.
ENQUIRIES:
Remote Monitored Systems plc
Trevor Brown (Executive Director) +41 7941 55384
Paul Ryan (Non-Executive Chairman) +32 475 754 148
SP Angel Corporate Finance LLP +44 20 3470 0470
Nominated Adviser and joint broker
Stuart Gledhill
Caroline Rowe
Peterhouse Capital Limited +44 20 7469 0930
Joint broker
Lucy Williams
Duncan Vasey
Follow the stocks
